Opioid Substitution Treatment
Conditions
Keywords
Anti-inflammatory agents non-steroidal
Brief summary
The purpose of this randomized controlled trial is to determine whether, ICE-T, a multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control compared to the standard narcotic based postoperative pain regimen in patients undergoing total laparoscopic gyn surgery.
Detailed description
Laparoscopy is a frequently used route for hysterectomy. Yet few studies have investigated opioid-sparing postoperative regimens for this common surgery. The study objective was to determine whether ice packs, Tylenol, and Toradol (ICE-T), an opioid-sparing multimodal postoperative pain regimen, has improved pain control compared with a standard opioid-centric postoperative pain regimen in total laparoscopic hysterectomy patients. The study was a randomized controlled trial. It included total laparoscopic hysterectomy postoperative patients that were randomized to the ICE-T or standard regimen. The ICE-T regimen prescribed scheduled around-the-clock ice-packs, acetaminophen and ketorolac. The standard protocol prescribed as needed ibuprofen and acetaminophen/oxycodone based on pain score. Both regimens included intravenous hydromorphone for breakthrough pain. However, subjects in the ICE-T group who requested additional narcotic medications prior to postoperative day 4, were prescribed supplemental narcotics in addition to the ICE-T regimen. The subjects pain control and quality of recovery were assessed on postoperative day 1 and 4.
Interventions
Use of non-steroidal anti-inflammatory drug for pain control postoperatively
Use of narcotic for pain control postoperatively
Placement of Ice packs on surgical sites postoperatively
Use of pain medication postoperatively
Use of non-steroidal anti-inflammatory drug for pain control postoperatively
Use of narcotic for pain control postoperatively
Use of combination tablet of Tylenol and Oxycodone for pain control postoperatively
Sponsors
Study design
Masking description
The randomized sequence was masked to all except the statistician who developed the sequence. Upon randomization, the participants, care providers, investigators and outcome assessors were aware of the participant study arm allocations.
Intervention model description
Enrolled patients were randomized at the end of surgery using sequentially numbered opaque sealed envelopes. A statistician developed the 1:1 mixed block randomization sequence using a random number generator; only the statistician was aware of the sequence. They were randomized to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.
Eligibility
Inclusion criteria
The inclusion criteria are the following: * Consenting, English speaking women between ages 18 and 80 who will undergo same day laparoscopic gyn surgery at MetroHealth Medical Center * Ability to read VAS Scores * Specific procedures include, but are not limited to: * Laparoscopic hysterectomy, for uterus 250 g or less * Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s) * Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s), with repair of enterocele * Laparoscopic hysterectomy, for uterus 250 g or less; with repair of enterocele * Laparoscopic hysterectomy, for uterus greater than 250 g * Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s) * Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele * Laparoscopic hysterectomy, for uterus greater than 250 g; with repair of enterocele
Exclusion criteria
* History of chronic pelvic pain * Abdominal surgery * History of psychiatric disease * Currently taking analgesic medications * Currently taking sedatives * Liver disease * Renal disease with CrCl \< 60cc/min. * History of burns from application of ice. * Women who did not consent for the study. * Intraoperative concern for increased blood loss * Unable to speak English * Unable to understand VAS Scores * Undergoing concomitant abdominal procedures. * Allergy to motrin, toradol, Percocet, Tylenol * Active or history of peptic ulcer disease * History of GI bleeding or perforation * Hemorrhagic diathesis * Severe uncontrolled heart failure * Inflammatory bowel disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| POD1 Visual Analog Pain (VAS) Score | Morning of post operative day 1 (~24 hours after surgery) | Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\ 24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| POD1 Quality of Recovery Score | Postoperative Day 1 | QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations. |
| 1st 24hr Total Dose of Narcotic | Total narcotic use from intra-op to 24 hours post-op | Total amount of narcotic in morphine equivalents administered to patients who were admitted for overnight extended recovery and/or observation. This includes narcotics given intra-operatively, in the post-anesthesia care unit and during their inpatient stay up until 24 hours postop. |
| Length of Stay | Post-operative Day 1 | Length of hospital stay measured in the number of nights spent at the hospital. Subjects were given the option for same-day discharge home from the PACU or overnight inpatient observation. |
| POD4 VAS Scores | VAS Scores at 4 days post-surgery. | Visual Analog Scores 4 days post-surgery. VAS pain score of 0 to a score of worst pain indicating a score of 10 (0=no pain and 10=being worst pain ever) |
| POD4 Satisfaction Score | Data collected as of postoperative day 4 | Patient's satisfaction with their pain management as of postoperative day 4, rated on a scale of 1 - 10, where 1 is very dissatisfied and 10 is very satisfied. |
| Time to First Bowel Movement | Up to post op day 4 | Time to first bowel movement in days |
| Oxycodone 5mg Doses Taken Since Discharge | Data collected as of Postoperative day 4 | The number of oxycodone 5mg doses (whether as oxycodone 5mg or as percocet 5/325) taken since discharge up until postoperative 4. |
| POD4 Quality of Recovery | Postoperative Day 4 | QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations. |
Other
| Measure | Time frame | Description |
|---|---|---|
| ICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen | Up until postoperative day 4 | Enrolled patients were randomized at the end of surgery to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications. |
Countries
United States
Participant flow
Recruitment details
Prior to surgery, patients will be asked to participate in the study in their private patient rooms or in medical clinic.
Pre-assignment details
111 patients were assessed for eligibility, but 45 were excluded (30 did not meet inclusion criteria, and 15 declined to participate). Therefore, 66 patients were randomized.
Participants by arm
| Arm | Count |
|---|---|
| ICE-T Toradol and Tylenol were given as pain management post-operative of total laparoscopic hysterectomy | 36 |
| Standard of Care (Control) Received routine pain management postoperative of laparoscopic hysterectomy | 30 |
| Total | 66 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 2 | 2 |
| Overall Study | Withdrawal by Subject | 1 | 0 |
Baseline characteristics
| Characteristic | ICE-T | Standard of Care (Control) | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 36 Participants | 30 Participants | 66 Participants |
| Body Mass Index | 31.0 kg/m^2 | 29.8 kg/m^2 | 30.8 kg/m^2 |
| Charlson Comorbidity Index | 0 Index | 0 Index | 0 Index |
| Current Smoker | 7 Participants | 9 Participants | 16 Participants |
| Depression/Anxiety | 1 Participants | 1 Participants | 2 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 4 Participants | 0 Participants | 4 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 32 Participants | 30 Participants | 62 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 2 Participants | 1 Participants | 3 Participants |
| Race (NIH/OMB) Black or African American | 19 Participants | 18 Participants | 37 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 4 Participants | 0 Participants | 4 Participants |
| Race (NIH/OMB) White | 11 Participants | 11 Participants | 22 Participants |
| Sex: Female, Male Female | 36 Participants | 30 Participants | 66 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
| STOP-BANG Score | 1.0 scores on a scale | 1.0 scores on a scale | 1.0 scores on a scale |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 36 | 0 / 30 |
| other Total, other adverse events | 7 / 36 | 3 / 30 |
| serious Total, serious adverse events | 0 / 36 | 0 / 30 |
Outcome results
POD1 Visual Analog Pain (VAS) Score
Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\ 24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)
Time frame: Morning of post operative day 1 (~24 hours after surgery)
Population: This population are participants that are approximately 24 hours post Total Laparoscopic Hysterectomy procedure. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | POD1 Visual Analog Pain (VAS) Score | 5.8 Score on a scale |
| STANDARD Postoperative Regimen | POD1 Visual Analog Pain (VAS) Score | 5 Score on a scale |
1st 24hr Total Dose of Narcotic
Total amount of narcotic in morphine equivalents administered to patients who were admitted for overnight extended recovery and/or observation. This includes narcotics given intra-operatively, in the post-anesthesia care unit and during their inpatient stay up until 24 hours postop.
Time frame: Total narcotic use from intra-op to 24 hours post-op
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The postoperative day 1 analysis outcomes included n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up. The subjects who chose same-day discharge were excluded from the analysis of total narcotic use within 24 hours post-op due to differences in reporting and access to medications. The analysis of this variable included n=27 ICE-T arm and n=23 Standard arm.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | 1st 24hr Total Dose of Narcotic | 77 oral morphine milligram equivalents |
| STANDARD Postoperative Regimen | 1st 24hr Total Dose of Narcotic | 111.5 oral morphine milligram equivalents |
Length of Stay
Length of hospital stay measured in the number of nights spent at the hospital. Subjects were given the option for same-day discharge home from the PACU or overnight inpatient observation.
Time frame: Post-operative Day 1
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | Length of Stay | 1 nights |
| STANDARD Postoperative Regimen | Length of Stay | 1 nights |
Oxycodone 5mg Doses Taken Since Discharge
The number of oxycodone 5mg doses (whether as oxycodone 5mg or as percocet 5/325) taken since discharge up until postoperative 4.
Time frame: Data collected as of Postoperative day 4
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | Oxycodone 5mg Doses Taken Since Discharge | 0 Doses |
| STANDARD Postoperative Regimen | Oxycodone 5mg Doses Taken Since Discharge | 7.0 Doses |
POD1 Quality of Recovery Score
QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.
Time frame: Postoperative Day 1
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | POD1 Quality of Recovery Score | 161.5 Score on a scale |
| STANDARD Postoperative Regimen | POD1 Quality of Recovery Score | 162.5 Score on a scale |
POD4 Quality of Recovery
QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.
Time frame: Postoperative Day 4
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | POD4 Quality of Recovery | 179.5 Score on a scale |
| STANDARD Postoperative Regimen | POD4 Quality of Recovery | 177.0 Score on a scale |
POD4 Satisfaction Score
Patient's satisfaction with their pain management as of postoperative day 4, rated on a scale of 1 - 10, where 1 is very dissatisfied and 10 is very satisfied.
Time frame: Data collected as of postoperative day 4
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | POD4 Satisfaction Score | 10.0 Score on a scale |
| STANDARD Postoperative Regimen | POD4 Satisfaction Score | 8.0 Score on a scale |
POD4 VAS Scores
Visual Analog Scores 4 days post-surgery. VAS pain score of 0 to a score of worst pain indicating a score of 10 (0=no pain and 10=being worst pain ever)
Time frame: VAS Scores at 4 days post-surgery.
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | POD4 VAS Scores | 3 Score on a scale |
| STANDARD Postoperative Regimen | POD4 VAS Scores | 4 Score on a scale |
Time to First Bowel Movement
Time to first bowel movement in days
Time frame: Up to post op day 4
Population: Patients that have undergone procedure were observed to see when they had their first bowel movement post-operation up to 4 days. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | Time to First Bowel Movement | 2 days |
| STANDARD Postoperative Regimen | Time to First Bowel Movement | 3 days |
ICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen
Enrolled patients were randomized at the end of surgery to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.
Time frame: Up until postoperative day 4
Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| ICE-T Opioid Sparing Regimen | ICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen | 8 Participants |